The mortality forecast for bladder malignant neoplasms among males in Japan shows an evident upward trend from 2024 to 2028 with values increasing gradually from 6.72 to 7.2 thousands. In 2023, this value stood slightly below 6.72 thousands, indicating a rise in mortality rates. The year-on-year percentage increase reflects consistent growth around 1.79%, pointing to a concerning trend. Over the five-year forecast period, the compound annual growth rate (CAGR) is approximately 1.76%, indicating a steady increase in mortality rates.
Future trends to watch include the impact of health policy interventions on bladder cancer management, potential breakthroughs in treatment, and increasing awareness programs which can alter these forecasted outcomes. Additionally, demographic shifts and lifestyle changes in Japan may further influence these mortality trends.
